BioRestorative Therapies, Inc. (BRTX) stock
BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
$1.49−0.01 (-0.67%)
Close on Nov 13, 2026Market cap $37.96MP/E –Yield –
BioRestorative Therapies ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
BioRestorative Therapies's ebitda for the twelve months ending Mar 31, 2026 was -$14.01M. For fiscal 2025 it was -$15.44M. The highest annual figure on record is -$2.02M in fiscal 2010.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$15.44M | – |
| FY2024 | Dec 31, 2024 | -$11.37M | – |
| FY2023 | Dec 31, 2023 | -$15.06M | – |
| FY2022 | Dec 31, 2022 | -$18.85M | – |
| FY2021 | Dec 31, 2021 | -$26.22M | – |
| FY2020 | Dec 31, 2020 | -$2.63M | – |
| FY2019 | Dec 31, 2019 | -$8.21M | – |
| FY2018 | Dec 31, 2018 | -$7.41M | – |
| FY2017 | Dec 31, 2017 | -$8.12M | – |
| FY2016 | Dec 31, 2016 | -$7.53M | – |
| FY2015 | Dec 31, 2015 | -$6.96M | – |
| FY2014 | Dec 31, 2014 | -$4.83M | – |
| FY2013 | Dec 31, 2013 | -$4.65M | – |
| FY2012 | Dec 31, 2012 | -$5.48M | – |
| FY2011 | Dec 31, 2011 | -$3.46M | – |
| FY2010 | Dec 31, 2010 | -$2.02M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$3.33M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.77M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.66M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.25M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.76M | – |
| Q4 FY2024 | Dec 31, 2024 | -$2.64M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.24M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.42M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.07M | – |
| Q4 FY2023 | Dec 31, 2023 | -$3.18M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.06M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.08M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.74M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.65M | – |
| Q3 FY2022 | Sep 30, 2022 | -$4.58M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.60M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.03M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.67M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.53M | – |
| Q1 FY2021 | Mar 31, 2021 | -$15.03M | – |
| Q4 FY2020 | Dec 31, 2020 | -$829.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$584.80K | – |
| Q2 FY2020 | Jun 30, 2020 | -$434.90K | – |
| Q1 FY2020 | Mar 31, 2020 | -$775.23K | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.10M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.76M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.08M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.28M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.12M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.13M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.99M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.17M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.51M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.68M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.50M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.43M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.79M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.65M | – |
| Q2 FY2016 | Jun 30, 2016 | -$2.08M | – |
See a number that looks wrong?